| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 2040 |
| 1 | PREDNISONE | 1413 |
| 2 | ACETAMINOPHEN | 1312 |
| 3 | DIPHENHYDRAMINE HYDROCHLORIDE | 1180 |
| 4 | VEDOLIZUMAB | 1125 |
| 5 | INFLIXIMAB | 1080 |
| 6 | ACETAMINOPHEN 500MG | 1016 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1016 |
| 8 | PAIN RELIEVER | 1016 |
| 9 | METHOTREXATE SODIUM | 832 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 819 | 0.2377 |
| 1 | GOLODIRSEN | 72 | 0.1475 |
| 2 | CASIMERSEN | 125 | 0.1268 |
| 3 | ETEPLIRSEN | 187 | 0.0775 |
| 4 | IDURSULFASE | 196 | 0.0492 |
| 5 | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | 5 | 0.0357 |
| 6 | VELAGLUCERASE ALFA | 66 | 0.0322 |
| 7 | BETAXOLOL HYDROCHLORIDE | 16 | 0.0307 |
| 8 | LARONIDASE | 107 | 0.0259 |
| 9 | EPINEPHRINE HYDROCHLORIDE | 12 | 0.0253 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 3165 |
| 1 | Corticosteroid [EPC] | 2195 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 1911 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1528 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 776 |
| 5 | Vitamin C [EPC] | 719 |
| 6 | Complement Inhibitor [EPC] | 709 |
| 7 | Vitamin B12 [EPC] | 647 |
| 8 | Vitamin D [EPC] | 588 |
| 9 | Provitamin D2 Compound [EPC] | 587 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 3165 | 0.0364 |
| 1 | Antisense Oligonucleotide [EPC] | 389 | 0.0326 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 396 | 0.0296 |
| 3 | Human C1 Esterase Inhibitor [EPC] | 113 | 0.0290 |
| 4 | Human Immunoglobulin G [EPC] | 546 | 0.0259 |
| 5 | Human alpha-1 Proteinase Inhibitor [EPC] | 99 | 0.0233 |
| 6 | Provitamin D2 Compound [EPC] | 587 | 0.0197 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 44 | 0.0183 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 132 | 0.0181 |
| 9 | Lysosomal beta Glucuronidase [EPC] | 1 | 0.0156 |